N/A
N=15,724
Intensive Monitoring of Renal Function
Intensive Monitoring of Renal Function · Acute Kidney Injury
Bottom Line
View on ClinicalTrials.gov: NCT02657226 ↗Enrolled (actual)
15,724
Serious AEs
—
Results posted
Jun 2019
Primary outcome: Primary: Detection of Acute Kidney Injury (AKI) — 1.22; 1.22; 1.11; 1.11 Odds Ratio
Study Design & Population
- Study type
- Observational
- Phase
- N/A
- Interventions
- —
- Age
- Adult, Older Adult · 18+ yrs
- Sex
- All
- Sponsor
- University of Pittsburgh
- Primary completion
- Jan 2017
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Detection of Acute Kidney Injury (AKI) |
1.22; 1.22; 1.11; 1.11 | — |
| SECONDARY Mortality |
0.90; 1.10 | — |
| SECONDARY Length of Stay in ICU |
8; 5 | — |
| SECONDARY Hospital Length of Stay |
17; 14 | — |
Summary
This study aims to examine the association between monitoring (Intensive and non-intensive) of renal function (urine output, serum creatinine) and outcomes among critically ill patients such as Acute Kidney Injury (AKI) and mortality.
Eligibility Criteria
Inclusion Criteria
- Critically ill patient admitted to ICU
- Required vasopressor support or mechanical ventilation in the 24 hours from ICU admission
Exclusion Criteria
- History of chronic dialysis and/or renal transplant
- Baseline serum creatinine >= 4 mg/dl
- Insufficient data to determine AKI stage in the 7 days from ICU admission
- Died within 48 hours from ICU admission
- ICU duration <2880 minutes
Data sourced from ClinicalTrials.gov (NCT02657226). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.